- Augmentation therapy for emphysema due to alpha-1 antitrypsin deficiency2017 | First Faculty of Medicine
- Augmentation therapy of COPD caused by α1-antiptrypsin deficiency2016 | First Faculty of Medicine
- Research priorities in alpha(1)-antitrypsin deficiency: results of a patients' and healthcare providers' international survey from the EARCO Clinical Research Collaboration2020 | First Faculty of Medicine
- Chronic obstructive pulmonary disease caused by alpha-1 antitrypsin deficiency and options concerning its treatment. What has the RAPID trial told us?2016 | First Faculty of Medicine
- Augmentation therapy of N-acetylcysteine for OCD: A meta-analysis of double-blind, randomized, placebo-controlled trials2019 | Faculty of Physical Education and Sport
- Long-term efficacy and safety of alpha 1 proteinase inhibitor treatment for emphysema caused by severe alpha 1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)2017 | First Faculty of Medicine
- European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency2017 | Faculty of Medicine in Hradec Králové
- Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats2010 | Central Library of Charles University
- Position statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression2012 | Publication without faculty affiliation
- The relation of radiological tumor volume response to histological response and outcome in patients with localized Ewing Sarcoma2019 | Second Faculty of Medicine